Quantification of staining in tumor tissues showed that 97% of GFP+ cells in control tumors also expressed CD45, 85% expressed CD11b, 62% expressed F4/80, and approximately 47% were CD68+ (Fig 2B). This evidence concerns the gene CD68 and neoplasm.